A new topical treatment for resistant herpes simplex infections.
Snoeck
R
R
Andrei
G
G
De Clercq
E
E
Gerard
M
M
Clumeck
N
N
Tricot
G
G
Sadzot-Delvaux
C
C
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004351:Drug Resistance; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D018139:Simplexvirus / Q000187:drug effects
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir